The prodrug nanoplatform might represent a novel strategy to enhance chemoradiotherapy of HNSCC and overcome PD‐L1‐dependent immune evasion through the JAK‐STAT pathway. Here, CD274 is linked to head and neck squamous cell carcinoma.